RPS6KA1 and myeloproliferative neoplasm: By scRNA-seq on serial MPN and sAML patients, increased DUSP6 expression along disease progression from MPN to sAML was found, which mediated JAK2 resistance by activating RSK1 and then S6 phosphorylation.